Answers are grounded in this paper and cite their sources.
This trial was monitored by both clinical and magnetic resonance imaging (MRI) methods. Clinical effect was a 30% reduction in relapse rate in the group treated with a high dose. The MRI activity rate was reduced by a median of 70% in both treatment groups. The burden of disease measure showed a clear-cut dose effect in the 2-year analysis. Future trials must be monitored by MRI. In addition, placebo controls will continue to be necessary in most trials, especially if long-term effects are to be measured.
No takes yet. Share an insight, caveat, or question.
Donald W. Paty (1994) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: